FDA Inspection
Solaris Pharma CorpSolaris Pharma Corp – FDA Inspection, Apr 21, 2026
Record Details
This FDA Inspection record concerns Solaris Pharma Corp, with an inspection on April 21, 2026, issued by the New Jersey District Office, covering human drugs.
View Company Profile
ID · b9f7b248-5c1f-4449-87fb-53f958ce2070
Inspection Facts
- Inspection number
- 1317052
- FDA center
- Human Drugs
Other FDA inspections of Solaris Pharma Corp
2| Date | Classification | Office | Project area |
|---|---|---|---|
| September 18, 2025 | VAI | New Jersey District Office | Postmarketing Surveillance and Epidemiology: Human Drugs |
| January 9, 2020 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Solaris Pharma Corp
- FDA Inspection 1283114 - 2025-09-18
- FDA Inspection 1117923 - 2020-01-09
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.